← Leaderboards
Marcie R Tomblyn
University Of Minnesota
$31,192
Attributed
$31,192
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $21.6K · FY2006–09$25K$18.8K$12.5K$6.3K$0
'06
'07
'08
'09
Funding mix
By agency
NIH$31,192 · 4
By mechanism
M01$31,192 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- Jeffrey S Miller$32,066,338
- Branden S Moriarity$9,306,595
- Bruce R. Blazar$144,460,093
- John E Wagner$7,593,142
- Jakub Tolar$8,610,650
Others in their field
Top investigators on “Institution”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,187,810,557
- Leonard Freedman · Leidos Biomedical Research, Inc.$835,530,754
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$566,554,288
- Bambra Strokes · Ppd Development Lp$526,656,217
Research focus
InstitutionInfectionImmunosuppressive AgentsBlood SpecimenCell PhysiologyAutologousAntigensAllogenicComputer Retrieval Of Information On Scientific Projects DatabaseCpg 7909CytotoxicityDefectDendritic CellsDoseEducational AspectsFundingGraft-Vs-Host DiseaseGrantHuman ResourcesImmuneImmune FunctionImmunityImmunologic AdjuvantsKeyhole Limpet Hemocyanin
Grant awards (4)
CLINICAL TRIAL: MT2003-03 CPG 7909 AFTER AUTOLOGOUS TRANSPLANTATION TO ENHANCE R$1,463
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: MT2003-03 CPG 7909 AFTER AUTOLOGOUS TRANSPLANTATION TO ENHANCE R$21,643
M01 · FY2008 · RR · contact PI
MT2003-03 CPG 7909 AFTER AUTOLOGOUS TRANSPLANTATION TO ENHANCE RECONSTITUTION$5,611
M01 · FY2007 · RR · contact PI
MT2003-03 CPG 7909 AFTER AUTOLOGOUS TRANSPLANTATION TO ENHANCE RECONSTITUTION$2,475
M01 · FY2006 · RR · contact PI